Published Year: 2023
Biomanufacturing Viral Detection and Quantification Market - A Global and Regional Analysis: Focus o
The global biomanufacturing viral detection and quantification market was valued at $474.3...
Market Research Report
A quick peek into the report
Table of Contents
1.1 Inclusion and Exclusion Criteria
2.1 Key Questions Answered in the Report
Research Methodology
4.1 Overview
4.2 Europe
4.2.1 Europe Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
4.2.2 Europe Biomanufacturing Viral Detection and Quantification Market (by Technology)
4.2.3 Europe Biomanufacturing Viral Detection and Quantification Market (by Application)
4.2.4 Europe Biomanufacturing Viral Detection and Quantification Market (by End User)
4.2.5 Europe Biomanufacturing Viral Detection and Quantification Market (by Country)
4.2.5.1 Germany
4.2.5.1.1 Germany Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
4.2.5.1.2 Germany Biomanufacturing Viral Detection and Quantification Market (by Technology)
4.2.5.1.3 Germany Biomanufacturing Viral Detection and Quantification Market (by Application)
4.2.5.1.4 Germany Biomanufacturing Viral Detection and Quantification Market (by End User)
4.2.5.2 U.K.
4.2.5.2.1 U.K. Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
4.2.5.2.2 U.K. Biomanufacturing Viral Detection and Quantification Market (by Technology)
4.2.5.2.3 U.K. Biomanufacturing Viral Detection and Quantification Market (by Application)
4.2.5.2.4 U.K. Biomanufacturing Viral Detection and Quantification Market (by End User)
4.2.5.3 France
4.2.5.3.1 France Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
4.2.5.3.2 France Biomanufacturing Viral Detection and Quantification Market (by Technology)
4.2.5.3.3 France Biomanufacturing Viral Detection and Quantification Market (by Application)
4.2.5.3.4 France Biomanufacturing Viral Detection and Quantification Market (by End User)
4.2.5.4 Spain
4.2.5.4.1 Spain Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
4.2.5.4.2 Spain Biomanufacturing Viral Detection and Quantification Market (by Technology)
4.2.5.4.3 Spain Biomanufacturing Viral Detection and Quantification Market (by Application)
4.2.5.4.4 Spain Biomanufacturing Viral Detection and Quantification Market (by End User)
4.2.5.5 Italy
4.2.5.5.1 Italy Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
4.2.5.5.2 Italy Biomanufacturing Viral Detection and Quantification Market (by Technology)
4.2.5.5.3 Italy Biomanufacturing Viral Detection and Quantification Market (by Application)
4.2.5.5.4 Italy Biomanufacturing Viral Detection and Quantification Market (by End User)
4.2.5.6 Rest-of-Europe
4.2.5.6.1 Rest-of-Europe Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
4.2.5.6.2 Rest-of-Europe Biomanufacturing Viral Detection and Quantification Market (by Technology)
4.2.5.6.3 Rest-of-Europe Biomanufacturing Viral Detection and Quantification Market (by Application)
4.2.5.6.4 Rest-of-Europe Biomanufacturing Viral Detection and Quantification Market (by End User)
5.1 Overview
5.2 Company Share Analysis
5.3 Biomanufacturing Viral Detection and Quantification Ecosystem Active Players
5.4 Merck KGaA
5.4.1 Company Overview
5.4.2 Role of Merck KGaA in the Biomanufacturing Viral Detection and Quantification Market
5.4.3 Key Competitors
5.4.4 Financials
5.4.5 Key Insights about the Financial Health of the Company
5.4.6 Analyst Perspective
5.5 Sartorius AG
5.5.1 Company Overview
5.5.2 Role of Sartorius AG in the Biomanufacturing Viral Detection and Quantification Market
5.5.3 Key Competitors
5.5.4 Financials
5.5.5 Analyst Perspective
5.6 QIAGEN N.V.
5.6.1 Company Overview
5.6.2 Role of QIAGEN N.V. in the Biomanufacturing Viral Detection and Quantification Market
5.6.3 Key Competitors
5.6.4 Financials
5.6.5 Key Insights about the Financial Health of the Company
5.6.6 Analyst Perspective
Table 1: Biomanufacturing Viral Detection and Quantification Market, Impact Analysis
Table 2: Key Questions Answered in the Report
Figure 1: Biomanufacturing Viral Detection and Quantification Market, $Billion, 2022-2032
Figure 2: Biomanufacturing Viral Detection and Quantification Market: Drivers, Restraints, and Opportunities
Figure 3: Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Billion, 2022-2032
Figure 4: Biomanufacturing Viral Detection and Quantification Market (by Technology), $Billion, 2022-2032
Figure 5: Biomanufacturing Viral Detection and Quantification Market (by Application), $Billion, 2022-2032
Figure 6: Biomanufacturing Viral Detection and Quantification Market (by Region), $Billion, 2022 and 2032
Figure 7: Biomanufacturing Viral Detection and Quantification Market: Research Methodology
Figure 8: Primary Research Methodology
Figure 9: Bottom-Up Approach (Segment-Wise Analysis)
Figure 10: Top-Down Approach (Segment-Wise Analysis)
Figure 11: Biomanufacturing Viral Detection and Quantification Market (by Region)
Figure 12: Europe: Market Dynamics
Figure 13: Europe Biomanufacturing Viral Detection and Quantification Market, $Billion, 2022-2032
Figure 14: Europe Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
Figure 15: Europe Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
Figure 16: Europe Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
Figure 17: Europe Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
Figure 18: Germany Biomanufacturing Viral Detection and Quantification Market, $Million, 2022-2032
Figure 19: Germany Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
Figure 20: Germany Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
Figure 21: Germany Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
Figure 22: Germany Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
Figure 23: U.K. Biomanufacturing Viral Detection and Quantification Market, $Million, 2022-2032
Figure 24: U.K. Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
Figure 25: U.K. Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
Figure 26: U.K. Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
Figure 27: U.K. Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
Figure 28: France Biomanufacturing Viral Detection and Quantification Market, $Million, 2022-2032
Figure 29: France Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
Figure 30: France Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
Figure 31: France Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
Figure 32: France Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
Figure 33: Spain Biomanufacturing Viral Detection and Quantification Market, $Million, 2022-2032
Figure 34: Spain Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
Figure 35: Spain Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
Figure 36: Spain Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
Figure 37: Spain Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
Figure 38: Italy Biomanufacturing Viral Detection and Quantification Market, $Million, 2022-2032
Figure 39: Italy Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
Figure 40: Italy Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
Figure 41: Italy Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
Figure 42: Italy Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
Figure 43: Rest-of-Europe Biomanufacturing Viral Detection and Quantification Market, $Million, 2022-2032
Figure 44: Rest-of-Europe Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
Figure 45: Rest-of-Europe Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
Figure 46: Rest-of-Europe Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
Figure 47: Rest-of-Europe Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
Figure 48: Biomanufacturing Viral Detection and Quantification Market, Total Number of Companies Profiled
Figure 49: Biomanufacturing Viral Detection and Quantification Market, Company Share Analysis, % Share, 2022
Figure 50: Merck KGaA: Product Portfolio
Figure 51: Merck KGaA: Overall Financials, $Million, 2020-2022
Figure 52: Merck KGaA: Revenue (by Segment), $Million, 2020-2022
Figure 53: Merck KGaA: Revenue (by Region), $Million, 2020-2022
Figure 54: Merck KGaA: R&D Expenditure, $Million, 2020-2022
Figure 55: Sartorius AG: Product Portfolio
Figure 56: Sartorius AG: Overall Financials, $Million, 2020-2022
Figure 57: Sartorius AG: Revenue (by Segment), $Million, 2020-2022
Figure 58: Sartorius AG: Revenue (by Region), $Million, 2020-2022
Figure 59: QIAGEN N.V.: Product Portfolio
Figure 60: QIAGEN N.V.: Overall Financials, $Million, 2020-2022
Figure 61: QIAGEN N.V.: Revenue (by Segment), $Million, 2020-2022
Figure 62: QIAGEN N.V.: Revenue (by Region), $Million, 2020-2022
Figure 63: QIAGEN N.V.: R&D Expenditure, $Million, 2020-2022
Europe Biomanufacturing Viral Detection and Quantification Market Report Coverage
|
Europe Biomanufacturing Viral Detection and Quantification Market |
|||
|
Base Year |
2022 |
Market Size in 2022 |
$137.3 Million |
|
Forecast Period |
2023-2032 |
Value Projection and Estimation by 2032 |
$345.9 Million |
|
CAGR During Forecast Period |
9.80% |
||
Key Market Players and Competition Synopsis
The companies that are profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, product portfolio, and regional presence.
Some of the prominent names in this market are:
• Merck KGaA
• Sartorius AG
• QIAGEN N.V.
How can this report add value to an organization?
Workflow/Innovation Strategy: The biomanufacturing viral detection and quantification market (by offering type) has been segmented into consumables, instruments, and services. Moreover, the study provides the reader with a detailed understanding of the different applications of biomanufacturing viral detection and quantification in raw material preparation, upstream processing, downstream processing, and packaging.
Growth/Marketing Strategy: Biomanufacturing viral detection and quantification is being used for raw material preparation, upstream processing, downstream processing, and packaging. Various companies are providing products and services to aid in the viral testing of various biologic production, which is also the key strategy for market players to excel in the current biomanufacturing viral detection and quantification market.
Competitive Strategy: Key players in the Europe biomanufacturing viral detection and quantification market have been analyzed and profiled in the study, including manufacturers. Moreover, a detailed competitive benchmarking of the players operating in the Europe biomanufacturing viral detection and quantification market has been done to help the reader understand how players stack against each other, presenting a clear market landscape.
Introduction to Europe Biomanufacturing Viral Detection and Quantification Market
The Europe biomanufacturing viral detection and quantification market was valued at $137.3 million in 2022 and is anticipated to reach $345.9 million by 2032, witnessing a CAGR of 9.80% during the forecast period 2023-2032. The growing use of biopharmaceutical products and improvements in viral testing technologies are expected to drive the growth of the biomanufacturing viral detection and quantification market in the European market.
Market Introduction
The market for viral detection and quantification biomanufacturing in Europe is expanding quickly as a result of the growing use of biopharmaceutical products. Ensuring the safety, efficacy, and consistency of these products becomes increasingly important as the demand for biologics develops. Sturdy quality control procedures are necessary to comply with regulations and preserve product integrity. One such procedure is the measurement of viral contamination during biomanufacturing. As a result, the European biomanufacturing viral detection and quantification market is experiencing a surge in demand for consumables and instruments. With technological improvements and a commitment to upholding high standards, the market is well-positioned for ongoing growth in the area.
Market Segmentation:
Segmentation 1: by Offering Type
• Consumables
• Instruments
• Services
Segmentation 2: by Technology
• PCR
• ELISA
• Flow Cytometry
• Plaque Assay
• Others
Segmentation 3: by Application
• Blood and Blood Products Manufacturing
• Vaccines and Therapeutics Manufacturing
• Cellular and Gene Therapy Products Manufacturing
• Stem Cell Products Manufacturing
• Tissue and Tissue Products Manufacturing
Segmentation 4: by End User
• Life Science Companies
• Testing Laboratories
• CROs and CDMOs
Segmentation 6: by Country
• Germany
• France
• U.K.
• Spain
• Italy
• Rest-of-Europe
Europe Biomanufacturing Viral Detection and Quantification Market
Analysis and Forecast, 2023-2032
Some Faq's
Frequently Asked Questions
The Europe biomanufacturing viral detection and quantification market was valued at $137.3 million in 2022 and is anticipated to reach $345.9 million by 2032, witnessing a CAGR of 9.80% during the forecast period 2023-2032 and the global biomanufacturing viral detection and quantification market was valued at $474.3 million in 2022 and is anticipated to reach $1,149.7 million by 2032, witnessing a CAGR of 9.37% during the forecast period 2023-2032.
Companies that manufacture and commercialize consumables and equipment required in the detection and quantification of viral contaminants during biopharmaceutical production.
Biomanufacturing viral detection and quantification refers to the process of identifying and measuring viral contaminants in biopharmaceutical manufacturing. During the production of biologics, such as vaccines, monoclonal antibodies, and gene therapies, it is crucial to ensure that the final products are free from viral impurities that could pose risks to patient safety.
Viral detection involves the use of various techniques, such as polymerase chain reaction (PCR), nucleic acid amplification tests (NAATs), enzyme-linked immunosorbent assays (ELISAs), and next-generation sequencing (NGS), to identify the presence of specific viral pathogens or viral nucleic acids.
Quantification, on the other hand, involves determining the amount or concentration of viral contaminants in a biopharmaceutical product, typically expressed as infectious units or viral particles per unit of volume.
Similar Product
You may also like